Genetic and molecular exploration of UHMK1 in schizophrenic patients

Psychiatric Genetics

Volumn 21, Issue 6, 2011, Pages 315-318

  Dumaine, Anne ^a,e   Maucuer, Alexandre ^f,g   Barbet, Aurélie ^f,g   Manceau, Valérie ^f,g   Deshommes, Jasmine ^a,d,e   Méary, Alexandre ^a,c,e   Szöke, Andrei ^a,c,e   Schürhoff, Franck ^a,b,c,e   Llorca, Pierre Michel ^e,h   Lancon, Christophe ^e,i   Leboyer, Marion ^a,b,c,e   Jamain, Stéphane ^a,e  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST   (France)

^c Groupe Hospitalier Albert Chenevier Henri Mondor   (France)

^d INSERM   (France)

^e FONDATION FONDAMENTAL   (France)

^f INSTITUT DU FER À MOULIN   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; PROTEIN; SPLICING FACTOR 1; U2AF HOMOLOGY MOTIF KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; META ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; SCHIZOPHRENIA;

EID: 80255137232     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283458a37     Document Type: Article

References (26)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Press.
2. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, et al. (2009). Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54:98-107.
3. Bieche I, Manceau V, Curmi PA, Laurendeau I, Lachkar S, Leroy K, et al. (2003). Quantitative RT-PCR reveals a ubiquitous but preferentially neural expression of the KIS gene in rat and human. Brain Res Mol Brain Res 114: 55-64.
4. Bristow GC, Lane TA, Walker M, Chen L, Sei Y, Hyde TM, et al. (2009). Expression of Kinase Interacting with Stathmin (KIS, UHMK1) in human brain and lymphoblasts: effects of schizophrenia and genotype. Brain Res 1301:197-206.
5. Brzustowicz LM (2008). NOS1AP in schizophrenia. Curr Psychiatry Rep 10:158-163.
6. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS (2000). Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
7. Bulayeva KB, Glatt SJ, Bulayev OA, Pavlova TA, Tsuang MT (2007). Genome-wide linkage scan of schizophrenia: a cross-isolate study. Genomics 89:167-177.
8. Cambray S, Pedraza N, Rafel M, Gari E, Aldea M, Gallego C (2009). Protein kinase KIS localizes to RNA granules and enhances local translation. Mol Cell Biol 29:726-735.
9. Etain B, Dumaine A, Mathieu F, Chevalier F, Henry C, Kahn JP, et al. (2010). A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain. Mol Psychiatry 15:748-755.
10. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, et al. (2001). Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661-673.
11. Heath SC, Gut IG, Brennan P, Mckay JD, Bencko V, Fabianova E, et al. (2008). Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet 16:1413-1429.
12. Hwu HG, Liu CM, Fann CS, Ou-Yang WC, Lee SF (2003). Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. Mol Psychiatry 8:445-452.
13. Langenickel TH, Olive M, Boehm M, San H, Crook MF, Nabel EG (2008). KIS protects against adverse vascular remodeling by opposing stathminmediated VSMC migration in mice. J Clin Invest 118:3848-3859.
14. Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA (2006). Making the case for a candidate vulnerability gene in schizophrenia: convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry 60: 534-537.
15. Lewis CM, Levinson DF,Wise LH, Delisi LE, Straub RE, Hovatta I, et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73:34-48.
16. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
17. Manceau V, Swenson M, Le Caer JP, Sobel A, Kielkopf CL, Maucuer A (2006). Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65. FEBS J 273:577-587.
18. Manceau V, Kielkopf CL, Sobel A, Maucuer A (2008). Different requirements of the kinase and UHM domains of KIS for its nuclear localization and binding to splicing factors. J Mol Biol 381:748-762.
19. Maucuer A, Ozon S, Manceau V, Gavet O, Lawler S, Curmi P, et al. (1997). KIS is a protein kinase with an RNA recognition motif. J Biol Chem 272:23151-23156.
20. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859. [Discussion 863-4].
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. (2007). PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 81:559-575.
22. Puri V, Mcquillin A, Choudhury K, Datta S, Pimm J, Thirumalai S, et al. (2007). Fine mapping by genetic association implicates the chromosome 1q23.3 gene UHMK1, encoding a serine/threonine protein kinase, as a novel schizophrenia susceptibility gene. Biol Psychiatry 61:873-879.
23. Puri V, Mcquillin A, Datta S, Choudhury K, Pimm J, Thirumalai S, et al. (2008). Confirmation of the genetic association between the U2AF homology motif (UHM) kinase 1 (UHMK1) gene and schizophrenia on chromosome 1q23.3. Eur J Hum Genet 16:1275-1282.
24. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006). Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209-213.
25. Sullivan PF (2005). The genetics of schizophrenia. PLoS Med 2:e212.
26. Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, et al. (2006). Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 60:152-162.